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The aim of the present study was to develop a simple and fast screening technique to
directly evaluate the bactericidal effects of 5-aminolevulinic acid (ALA)-mediated
photodynamic inactivation (PDI) and to determine the optimal antibacterial conditions
of ALA concentrations and the total dosage of light in vitro. The effects of PDI on
Staphylococcus aureus and Pseudomonas aeruginosa in the presence of various concen-
trations of ALA (1.0 mM, 2.5 mM, 5.0 mM, 10.0 mM) were examined. All bacterial strains
were exponentially grown in the culture medium at room temperature in the dark for
60 minutes and subsequently irradiated with 630  5 nm using a light-emitting diode
(LED) red light device for accumulating the light doses up to 216 J/cm2. Both bacterial
species were susceptible to the ALA-induced PDI. Photosensitization using 1.0 mM ALA
with 162 J/cm2 light dose was able to completely reduce the viable counts of S. aureus. A
significant decrease in the bacterial viabilities was observed for P. aeruginosa, where
5.0 mM ALA was photosensitized by accumulating the light dose of 162 J/cm2. We
demonstrated that the use of microplate-based assaysdby measuring the apparent
optical density of bacterial colonies at 595 nmdwas able to provide a simple and reli-
able approach for quickly choosing the parameters of ALA-mediated PDI in the cell
suspensions.
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The widespread inappropriate use of antibiotics has resulted
in multiresistant bacterial strains and increased rates of
infection [1,2]. This health care problem is therefore particu-
larly urgent because there is a clear need for a more effective
anti-infective strategy against these organisms. Many of the
new antibiotics are more potent, but they also increase the
risk of systemic toxicity. The versatility and potency of
photodynamic therapy (PDT) may be an interesting alterna-
tive choice against many types of microorganisms and the
lack of resistance with repeated use [3]. Basically, PDT is the
result of the use of three autonomously nonactive elements in
combination: (1) a nontoxic photoactive molecule called a
photosensitizer (PS); (2) light of the appropriate wavelength to
excite the PS; and finally, (3) oxygen, which is transformed
into the highly reactive singlet oxygen species upon energy
transfer from the light-activated PS.
The photodynamic effect uses nontoxic dyes or PS in
combination with exposure to harmless visible light in the
presence of oxygen to induce the generation of highly reac-
tive, cytotoxic reactive oxygen species, causing selective
photodamage to tumor tissues or leading to localized cell
death [4]. It provides the following advantages for treatment of
microbial infections: (1) broad light spectrum of action; (2)
efficient inactivation of antibiotic-resistant strains; (3) low
mutagenic potential; and (4) less likelihood of inducing pho-
toresistant cells [5,6]. Bacterial organisms such as Gram-
positive bacteria can be killed by photodynamic inactivation
(PDI) in vitro with exogenous PS such as porphyrins. The
complex outer membrane of Gram-negative bacteria acts as a
barrier that hinders the PS to transport through the cell
membranes; hence, Gram-negative bacteria appear to be less
sensitive to the lethal action of PDI with exogenously supplied
porphyrins [7e9].
5-Aminolevulinic acid (ALA) is a naturally occurring inter-
mediate in the hemesynthesis pathway [10]. It is a precursor
of porphyrins that can be biosynthesized in nearly all aerobic
cells in mammals. The first topical application of ALA in the
treatment of basal cell carcinoma was reported in 1990 [11];
since then, the clinical use of ALA-PDT continues to grow.
ALA-PDT has been widely studied and marketed around the
world [12], and the methyl-ester derivative of ALA has been
approved for the treatment of basal cell carcinoma and actinic
keratosis [13]. In addition, the EuropeanMedicines Agency has
approved the hexyl-ester derivative of ALA for diagnostic
application in endoscopic photodynamic detection of bladder
cancer and ALA for intraoperative photodiagnosis of residual
malignant glioma [14].
The reasons why ALA was extensively used in the field of
PDT can be summarized as follows: (1) ALA is the only PDT
agent that is a biochemical precursor of a PS, which is natu-
rally produced by the body, and alone shows low dark toxicity
to cells; (2) the topical delivery of ALA does not induce any
prolonged photosensitivity reactions, because the drug can be
selectively applied in areas to be treated; (3) endogenously
produced protoporphyrin IX is rapidly cleared from the body
(24e48 hours), because it has a natural clearance mechanism;
and (4) the short time interval (1e8 hours, depending on themode of administration) needed between the administration
of ALA and themaximal accumulation of protoporphyrin IX in
target tissues makes ALA attractive for patients.
Furthermore, ALA has been shown to have considerable
photobactericidal activity. Compared to exogenously admin-
istered hydrophobic porphyrin derivatives, ALA is highly
water soluble andmay enter the intracellular compartment of
Gram-negative bacteria through the hydrophilic pores of its
outer membrane [15]. Treatment with exogenous ALA could
effectively accumulate considerable amounts of photoactive
porphyrins (PAPs) within the targeted cells [16]. Under the
irradiation of the appropriate wavelength of light, the accu-
mulated porphyrins will induce PDI to destroy the cells [17].
Recently, a few reports showed that ALA could induce PDI
effectively against various kinds of bacterial strains such as
Gram-positive Staphylococcus aureus and Gram-negative bac-
teria Pseudomonas aeruginosa and Escherichia coli [18e24].
Although PDI of bacteria has been known for more than
100 years [25], its use for treatment of infections has not been
extensively developed [26]. This may be partly attributable to
the lack of a standardized and reliable in vitro screening
method to evaluate the antibacterial efficacy of PDT. Our
study aimed to assess the effectiveness of ALA-mediated PDI
on S. aureus and P. aeruginosa by directly judging the apparent
optical density (OD) caused by light scattering of colonies and
further to determine the optimal antibacterial conditions of
ALA doses and light exposure in vitro. We have developed a
more economic and rapid in vitro screening technique to
evaluate the antimicrobial activity of ALA-PDT in contrast to
the traditional antibacterial susceptibility testing.2. Materials and methods
2.1. Materials
ALA and phosphate buffer solution (PBS) were purchased from
Sigma-Aldrich (St. Louis, MO, USA). Nutrient broth medium
(BD 234000) and nutrient agar medium (BD 4311472) were
purchased from Difco (Detroit, MI, USA).
2.2. Preparation of ALA solution
A stock solution of 100 mM ALA was prepared by dissolving
ALA in 0.1 M PBS (pH 7.4) prior to the experiment. The ALA
stock and diluted solutions were used within 2 hours after the
preparation to ensure its stability.
2.3. Bacterial strains and growth conditions
This study was conducted with a Gram-negative strain
(P. aeruginosa; American Type Culture Collection Strain 27853)
and a Gram-positive strain (S. aureus; American Type Culture
Collection Strain 29213) purchased from the Bioresource
Collection and Research Center (Hsinchu, Taiwan). The
strainswere grown in nutrient broth separately for 24 hours at
37C in a humidified atmosphere of 95% air and 5% CO2
controlled by a low-temperature incubator (LE-509; YIH DER
Instruments, Taipei, Taiwan). The broth cultures were then
spread on nutrient agar medium and then incubated at 37C
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 2 ( 2 0 1 4 ) 3 5 0e3 5 5352for 24 hours. This incubation process was repeated for three
times to produce the bacterial strains containing approxi-
mately 108 colony-forming units (CFU)/mL.2.4. PDI of bacterial cells
For PDI, bacterial cells in the broth cultures were centrifuged,
washed three times with PBS, and then suspended in PBS to
obtain a cell suspension about 108 CFU/mL. Aliquots of sus-
pensions (0.1 mL) were transferred into 96-well plates, and
then 0.1 mL of different concentrations of ALA solution
(0e10mM)was added. Sampleswere incubated for 60minutes
in the dark and then irradiated at room temperature (ca. 25C).
The light source used for ALA irradiation consisted of a high-
power light-emitting diode (LED) array with the wavelength
centered at 635 5 nm,with an irradiance set as required light
doses [27]. The irradiated and nonirradiated bacterial cells
(10 mL) were serially diluted 10-fold with PBS and incubated
for an additional 18 hours at 37C.
The apparent ODs caused by light scattering of colonies
were measured by using a Microplate Autoreader (EL311; Bio-
Tek Instruments,Winooski, VT, USA) at 595 nm; the OD values
were subsequently calibrated with the CFU obtained by plate
counts. Afterward, the CFU can be easily calculated from the
calibration curve (see Fig. 1A for S. aureus and Fig. 1B for
P. aeruginosa) by interpolating the measured OD value. All re-
sults are expressed as the mean  standard deviation. Dif-
ferences between two means were assessed for significance
by the two-tailed Student t test, and a p < 0.05 was considered
statistically significant.Fig. 1 e Calibration curves of optical density (595 nm)
versus bacterial concentration: (A) Staphylococcus aureus
and (B) Pseudomonas aeruginosa. All data are expressed as
the mean ± standard deviation.2.5. Bacterial cell survival assay
The numbers of CFU of a bacterial suspension were deter-
mined by plating appropriate dilutions (from 101 to 105) on
trypticase soy broth agar plates. The survival fraction was
calculated as NPDI/N0, where NPDI is the number of CFU per
milliliter after PDI and N0 is the number of CFU permilliliter in
the initial sample. The dark toxicity of the substrates, defined
as the intrinsic toxicity of the compounds in the absence of
light, was monitored by evaluating the survival fraction of
incubated but nonilluminated bacterial samples and was
calculated as Ndark/N0, where Ndark is the number of CFU per
milliliter of the nonilluminated samples. The results were
expressed as mean values (n ¼ 3) with their standard
deviations.3. Results and discussion
3.1. Dark toxicity of ALA on the bacterial strains
Preliminary experiments were carried out in order to confirm
the relationship between CFU value and OD. As shown in
Fig. 1, significant positive correlations between the colonies of
both bacterial strains and the measured light responses were
observed (R2 ¼ 0.9804 for S. aureus in Fig. 1A; R2 ¼ 0.9965 for
P. aeruginosa in Fig. 1B). Therefore, the use of OD to estimate
CFU value in a suspension was proven to be a simple and
applicable method for the following experiments.
The bacterial cultures (S. aureus and P. aeruginosa) were
incubated in the dark for 60 minutes with ALA at various
concentrations in order to evaluate the dark toxicity of ALA.
For S. aureus, the trends of gradually increasing ODs with time
were consistent with the control group (incubated without
ALA, data not shown); the bacterial survival of S. aureus was
not affected by ALA when incubated in the dark, indicating
that ALA induced no dark toxicity on S. aureus cells. On the
contrary, the number of surviving colonies of P. aeruginosa
(calculated by interpolating the measured OD value into
Fig. 1B) was partly inhibited by higher ALA concentrations
(5.0 mM and 10.0 mM), whereas negligible reductions in the
surviving colonies were found in the conditions of 1.0 mM and
2.5 mM ALA (data not shown). The growth inhibition of
P. aeruginosa observed here is possibly due to higher concen-
trations of ALA, which leads to the increasing acidification of
the culture. A lower pH culture medium was reported to
exhibit a rapid bactericidal effect against Gram-negative bac-
teria such as P. aeruginosa, but this effect was not observed on
Gram-positive bacteria [28]. In addition, the finding seemed to
suggest that pretreatment with ALA is likely to strengthen the
bactericidal effects on P. aeruginosa.
3.2. PDI against S. aureus
The effects of photoirradiation doses on S. aureuswith various
ALA concentrations were studied. As shown in Fig. 2A, when
S. aureus was incubated with different concentrations of ALA
and exposed to 216 J/cm2 of red light (irradiated for 120 mi-
nutes), a significant reduction in the surviving cells can be
achieved regardless of ALA concentrations, even in the
Fig. 2 e 5-Aminolevulinic acid (ALA)-induced photodynamic inactivation against Staphylococcus aureus in the presence of
0 mM, 1.0 mM, 2.5 mM, 5.0 mM, and 10.0 mM ALA. Photoirradiation time was set at (A) 120 minutes, (B) 90 minutes, (C)
60 minutes, and (D) 30 minutes for accumulating light doses of 216 J/cm2, 162 J/cm2, 108 J/cm2, and 54 J/cm2, respectively. All
data are expressed as the mean ± standard deviation.
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strated that PDI against S. aureus was induced successfully by
ALA at the condition. As with reducing the photoirradiation
dose to 162 J/cm2 (Fig. 2B), a significant reduction in the sur-
viving cells was also observed after 90 minutes of irradiation
(treated with 1.0 mMALA), and no further proliferations could
be detected thereafter in all experimental groups. Slightly
different results were found in Fig. 2C and 2D (108 J/cm2 and
54 J/cm2 light doses, respectively), wherein the cell pro-
liferations of irradiated samples were suppressed during
photoirradiation, whereas the bacterial survival of S. aureus
incubated with various ALA concentrations gradually grew
once the light was removed. To summarize the results, anFig. 3 e 5-Aminolevulinic acid (ALA)-induced photodynamic ina
0 mM, 1.0 mM, 2.5 mM, 5.0 mM, and 10.0 mM ALA. Photoirradi
(C) 60 minutes, and (D) 30 minutes for accumulating light doses o
All data are expressed as the mean ± standard deviation.economic and time-saving formulation to effectively induce
PDI against S. aureus could be obtained through incubation
with 1.0 mM of ALA and exposure to 162 J/cm2 of light dose.3.3. PDI against P. aeruginosa
When the period of photoirradiation was increased from 30 to
120 minutes, the bacterial killing of P. aeruginosa gradually
increased as shown in Fig. 3. In the presence of 1.0 mM ALA,
the reduction in surviving cells (taken from interpolating the
OD values to the calibration curve) was estimated to be about
2.3 log, 3.3 log, 4.0 log, and 4.7 log, whereas irradiating time
was set as 30 minutes, 60 minutes, 90 minutes, andctivation against Pseudomonas aeruginosa in the presence of
ation time was set at (A) 120 minutes, (B) 90 minutes,
f 216 J/cm2, 162 J/cm2, 108 J/cm2, and 54 J/cm2, respectively.
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liferations took place once the photoirradiation was stopped,
which means that PDI mediated by 1.0 mM ALA seemed to be
ineffective against P. aeruginosa. While increasing the admin-
istration of ALA to 2.5mM, 3.0 log, 4.1 log, 5.3 log, and 6.3 log of
cells were killed when irradiated with 30minutes, 60minutes,
90 minutes, and 120 minutes of light, respectively. The cell
proliferations could still be observed after the LED light source
was removed. Treatment with 5 mM of ALA gave approxi-
mately 6.5-log reduction in the viable count if the light dose
was 162 J/cm2; no surviving cells could be detected if 10 mM of
ALA was administered with the same light dose of 162 J/cm2
(Fig. 3B). These data suggested that 5 mM of ALA with a 162 J/
cm2 light dose may be useful for PDI against P. aeruginosa.3.4. Survival fractions of S. aureus and P. aeruginosa
The survival fractions were calculated by counting the num-
ber of CFUs to confirm the efficacy of ALA-medicated PDI
again S. aureus and P. aeruginosa. As shown in Fig. 4, both
survival fractions of S. aureus and P. aeruginosawere decreased
with increasing ALA concentrations under the same light
exposure (162 J/cm2). The Gram-positive organism S. aureus
appeared to be significantlymore sensitive to 5-ALA-mediated
PDI than the Gram-negative strains (e.g., survival fraction,
8.0 vs. 5.3 when administered 2.5 mM of ALA). By contrast,
the survival fraction of S. aureus reached a plateau value
(survival fraction: 8.0) when the lower concentration of ALA
was administered (2.5 mM), whereas it needed 10 mM of ALA
administered in order to reach the same efficiency of PDI
when used against P. aeruginosa. To summarize, our results
are in line with the statement from the literature as
mentioned earlier. The main reason for the effects of ALA-
mediated PDI on Gram-negative and Gram-positive bacteria
is attributed to the complex outer membrane of Gram-
negative bacteria acting as a barrier that hinders PS to trans-
port through the cellmembrane; thus, Gram-negative bacteria
appear to be less sensitive to the lethal action of PDI with
exogenously supplied porphyrins [7e9]. Furthermore, the re-
sults also correlatedwell with the previous data obtained from
a microplate autoreader.
Although the addition of ALA with higher concentrations
showed somewhat dark toxicities on P. aeruginosa, the efficacyFig. 4 e Log survival fractions of Staphylococcus aureus and
Pseudomonas aeruginosa treated with 5-aminolevulinic acid
(ALA) at various concentrations after 90 minutes of light
exposure (162 J/cm2).of PDI mediated by ALA against S. aureuswas still higher than
that against P. aeruginosa. This phenomenon may be attrib-
uted to the fact that Gram-positive strains accumulate much
more PAPs than Gram-negative strains: as more PAPs were
accumulated, the more singlet oxygen was produced upon
illumination and thus inactivated the bacterial cells [19].
The traditional enumeration of bacteria by direct plate
counting on nutrient agarmedium requires laborious dilution,
an incubation process that is complicated and time
consuming. Our study thus provides an efficient and reliable
way for rapid screening the effects of PDI induced by ALA
againstmicroorganism species bymeasuring the apparent OD
with a microplate autoreader.4. Conclusions
The present study suggests that ALA in combination with red
LED light is a potential candidate for PDI against S. aureus and
P. aeruginosa. The use of OD to estimate CFUs in cell suspen-
sions is proven to be a rapid, low-cost, and nondestructive
alternative for optimizing the experimental conditions of ALA-
induced PDI on bacterial strains. We believe that microplate-
based assays could represent a very good alternative to the
conventional colony count method in testing the antibacterial
potential of different photocatalytic and other materials.Conflicts of interest
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